Berenberg Bank reaffirmed their buy rating on shares of Whitbread (LON:WTB – Free Report) in a research note issued to investors on Thursday, Digital Look reports. Berenberg Bank currently has a GBX 4,000 ($51.93) price objective on the stock.
Several other equities analysts also recently issued reports on the company. Shore Capital reiterated a “buy” rating on shares of Whitbread in a research report on Wednesday, October 16th. Jefferies Financial Group lifted their target price on Whitbread from GBX 39 ($0.51) to GBX 40 ($0.52) and gave the company a “buy” rating in a research note on Tuesday, August 20th. Finally, The Goldman Sachs Group downgraded Whitbread to a “neutral” rating in a research report on Wednesday, September 18th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of GBX 2,746.67 ($35.66).
Get Our Latest Research Report on WTB
Whitbread Price Performance
Whitbread Cuts Dividend
The business also recently declared a dividend, which will be paid on Friday, December 6th. Stockholders of record on Thursday, October 31st will be paid a GBX 34.60 ($0.45) dividend. The ex-dividend date of this dividend is Thursday, October 31st. This represents a dividend yield of 1.13%. Whitbread’s dividend payout ratio (DPR) is presently 6,062.50%.
About Whitbread
Whitbread plc operates hotels and restaurants in the United Kingdom, Germany, and internationally. It operates hotels with rooms in the United Kingdom; Middle East; and Germany under the Premier Inn, ZIP by Premier Inn, and hub by Premier Inn brands. The company operates restaurants under the Brewers Fayre, Beefeater, Cookhouse & Pub, Bar+Block Steakhouse, Thyme, and Table Table brands in the United Kingdom.
Featured Articles
- Five stocks we like better than Whitbread
- What Are Dividend Challengers?
- Texas Roadhouse Stock Steering for New Highs This Year
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Investing In Preferred Stock vs. Common Stock
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Whitbread Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Whitbread and related companies with MarketBeat.com's FREE daily email newsletter.